Metrology for metalloproteins—where are we now, where are we heading?

被引:0
|
作者
Claudia Swart
机构
[1] Physikalisch-Technische Bundesanstalt,
来源
关键词
Clinical/biomedical analysis; Metalloproteins; Reference materials; Reference measurement procedures;
D O I
暂无
中图分类号
学科分类号
摘要
The use of the amount of certain proteins in biological samples as markers for distinguishing between a healthy and a diseased state has become increasingly important in clinical diagnosis. As about 30 % of all proteins contain metals in one form or another, either as a cofactor or covalently bound as part of the protein, some of these proteins are regularly analyzed in clinical laboratories. With the increasing number of measurements of those proteins performed all over the world, the necessity of obtaining reliable and comparable results is becoming a focal point for scientists and politicians. Directives such as the EC directive covering in vitro diagnostic medical devices (Directive 98/79/EC) and standards such as EN ISO 17511:2003 demand the traceability of the results obtained for analytes in samples of human origin. However, no reference measurement procedures with results traceable to the SI exist for many metalloproteins. In this article, the situation for a few important metalloproteins, such as hemoglobin, transferrin, superoxide dismutase, ceruloplasmin, and C-reactive protein, for which specific efforts have been made in recent years to achieve comparable and traceable results worldwide, is discussed. These proteins also serve as examples of the difficulties scientists face when they wish to quantify proteins and the pitfalls they should avoid to achieve reliable results.
引用
收藏
页码:5697 / 5723
页数:26
相关论文
共 50 条
  • [1] Metrology for metalloproteins-where are we now, where are we heading?
    Swart, Claudia
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (17) : 5697 - 5723
  • [2] Echocardiography: where are we now and where are we heading?
    Picard, MH
    [J]. WHAT'S NEW IN CARDIOVASCULAR IMAGING?, 1998, 204 : 323 - 331
  • [3] Amyloidosis-Where Are We Now and Where Are We Heading?
    Picken, Maria M.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (04) : 545 - 551
  • [4] Naturopathy in Australia: Where are we now? Where are we heading?
    Ooi, Soo Liang
    McLean, Lisa
    Pak, Sok Cheon
    [J]. COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2018, 33 : 27 - 35
  • [5] Aligner biomechanics: Where we are now and where we are heading for
    Castroflorio, Tommaso
    Parrini, Simone
    Rossini, Gabriele
    [J]. JOURNAL OF THE WORLD FEDERATION OF ORTHODONTISTS, 2024, 13 (02) : 57 - 64
  • [6] Zirconia dental implants: where are we now, and where are we heading?
    Cionca, Norbert
    Hashim, Dena
    Mombelli, Andrea
    [J]. PERIODONTOLOGY 2000, 2017, 73 (01) : 241 - 258
  • [7] Women entrepreneurship in China: where are we now and where are we heading
    Cooke, Fang Lee
    Xiao, Mengtian
    [J]. HUMAN RESOURCE DEVELOPMENT INTERNATIONAL, 2021, 24 (01) : 104 - 121
  • [8] Minimally Invasive THA: Where Are We Now and Where Are We Heading?
    Eskelinen, Antti
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2017, 99 (20):
  • [9] Serverless Computing-Where Are We Now, and Where Are We Heading?
    Taibi, Davide
    Spillner, Josef
    Wawruch, Konrad
    [J]. IEEE SOFTWARE, 2021, 38 (01) : 25 - 31
  • [10] Electrostatics in biomolecular simulations: Where are we now and where are we heading?
    Karttunen, Mikko
    Rottler, Joerg
    Vattulainen, Ilpo
    Sagui, Celeste
    [J]. COMPUTATIONAL MODELING OF MEMBRANE BILAYERS, 2008, 60 : 49 - 89